Select Page

Supplemental Measures to Enhance Duodenoscope Reprocessing: FDA Communication

Home Forums Infexion Connexion Supplemental Measures to Enhance Duodenoscope Reprocessing: FDA Communication

 | Click to Receive Email Notifications of Posts
  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #72356
    Glenys Harrington
    Participant

    Author:
    Glenys Harrington

    Position:
    Consultant

    Organisation:
    Infection Control Consultancy (ICC)

    State:

    Dear All
    Further to my previous postings about the CRE outbreak in the USA
    relating to the reprocessing of duodenoscopes.

    This week the FDA has released “Supplemental Measures to Enhance
    Duodenoscope Reprocessing”. This information can be accessed at the
    link below.

    Your colleagues in endoscopy may be interested in this information.
    http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm

    regards

    Glenys

    Glenys Harrington
    Consultant
    Infection Control Consultancy (ICC)
    PO Box 5202
    Middle Park
    Victoria, 3206
    Australia
    M: +61 404 816 434
    infexion@ozemail.com.au ABN 47533508426

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.